Abstract
Lipopolysaccharide (LPS) inhalation (30 microg ml(-1), 1 h) caused airway hypereactivity (AHR) to histamine (1 mM, 20 s) 1 h later in conscious guinea-pigs. Bronchoalveolar lavage fluid (BALF) levels of neutrophils, myeloperoxidase (MPO) and protein were elevated whereas nitric oxide (NO) metabolites were reduced 1 h after LPS compared with saline challenge. 24 h after LPS, there was no AHR, but BALF neutrophils, eosinophils, macrophages, MPO, protein and NO metabolites were all raised. Budesonide (0.7 mM) and a molar equivalent concentration of the NO-donating budesonide derivative, NCX 1020, were inhaled (15 min) at 24 h and 45 min before LPS. The only change produced by budesonide was to reduce eosinophil influx at 24 h after LPS, compared with vehicle treated animals. NCX 1020, however, blocked AHR and reduced neutrophils (1 and 24 h) and MPO (1 and 24 h), while NO levels were raised at 1 and reduced at 24 h after LPS. The combined inhalation before LPS of the NO donor, SNAP (1.4 mM), with budesonide (0.7 mM) blocked the AHR to histamine and significantly reduced neutrophils (1 and 24 h) and MPO (1 and 24 h), while NO levels were raised at 1 h after LPS. Thus, NO and a corticosteroid co-administered as NCX 1020 or budesonid...Continue Reading
References
Dec 1, 1989·The American Review of Respiratory Disease·A B ThompsonS I Rennard
Jul 1, 1995·The Journal of Clinical Investigation·R De CaterinaJ K Liao
Mar 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·C J WhelanG P Wren
Jul 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H O HeuerK Urich
May 1, 1996·British Journal of Anaesthesia·J D YoungE M Valvini
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·B V KhanR M Medford
May 17, 1997·Lancet·C J Murray, A D Lopez
Jun 12, 1998·The European Respiratory Journal·C G PerssonC Svensson
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·K HondaT Tomita
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·K R WalleyS Hayashi
Nov 5, 1999·Critical Care Medicine·F BaigorriL Blanch
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·M IchinoseK Shirato
Aug 8, 2001·The European Respiratory Journal·K AnsarinK R Chapman
Jan 18, 2002·Journal of Applied Physiology·Jihee Lee KangYounsuck Koh
Jan 31, 2002·Annual Review of Medicine·Lee Maddox, David A Schwartz
May 16, 2002·Chest·Robert A Stockley
Nov 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Stefano FiorucciLouis J Ignarro
Citations
Apr 7, 2012·Journal of Allergy·T SecherM Russo
Jun 27, 2009·European Journal of Clinical Pharmacology·Kian Fan ChungIan M Adcock
Jul 19, 2005·Expert Opinion on Investigational Drugs·Roberto ScatenaBruno Giardina
Jul 20, 2010·European Journal of Pharmacology·Dawn L TurnerKenneth J Broadley
Nov 26, 2009·Pharmacology & Therapeutics·Robert NewtonMark A Giembycz
May 9, 2012·British Journal of Pharmacology·D l TurnerK J Broadley
Jun 27, 2006·Pulmonary Pharmacology & Therapeutics·Néstor A Molfino, Peter K Jeffery
Feb 10, 2006·European Journal of Pharmacology·Anthony E Redington
Mar 17, 2009·Respiratory Medicine·Louis-Philippe BouletPaolo M Renzi
Sep 23, 2008·Lancet·Ian M AdcockK Fan Chung
Dec 21, 2006·International Immunopharmacology·Nicola Smith, Kenneth J Broadley
Jun 12, 2010·Journal of Applied Physiology·Sofia JonassonJosephine Hjoberg
May 23, 2012·Pharmacological Reviews·Mario CazzolaM Gabriella Matera
Sep 29, 2020·Journal of Experimental Pharmacology·Paola RoglianiLuigino Calzetta